205 related articles for article (PubMed ID: 24895642)
1. Serum fibroblast growth factor 21 levels are correlated with the severity of diabetic retinopathy.
Lin Y; Xiao YC; Zhu H; Xu QY; Qi L; Wang YB; Li XJ; Zheng ML; Zhong RS; Zhang Y; Xu XD; Wu BL; Xu ZM; Lu XH
J Diabetes Res; 2014; 2014():929756. PubMed ID: 24895642
[TBL] [Abstract][Full Text] [Related]
2. Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients.
Esteghamati A; Momeni A; Abdollahi A; Khandan A; Afarideh M; Noshad S; Nakhjavani M
Ann Endocrinol (Paris); 2016 Oct; 77(5):586-592. PubMed ID: 27106505
[TBL] [Abstract][Full Text] [Related]
3. The serum fibroblast growth factor 21 is correlated with retinopathy in patients with type 2 diabetes mellitus.
Heidari Z; Hasanpour M
Diabetes Metab Syndr; 2021; 15(6):102296. PubMed ID: 34592531
[TBL] [Abstract][Full Text] [Related]
4. The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus.
Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
J Diabetes Complications; 2017 Jan; 31(1):134-140. PubMed ID: 27839924
[TBL] [Abstract][Full Text] [Related]
5. Association between serum fibroblast growth factor 21 level and sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes.
Jin S; Xia N; Han L
BMJ Open Diabetes Res Care; 2021 Mar; 9(1):. PubMed ID: 33789910
[TBL] [Abstract][Full Text] [Related]
6. Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
Taniguchi H; Nirengi S; Ishihara K; Sakane N
PLoS One; 2022; 17(2):e0263774. PubMed ID: 35192641
[TBL] [Abstract][Full Text] [Related]
7. FGF21 and glycemic control in patients with T1D.
Rosell Rask S; Krarup Hansen T; Bjerre M
Endocrine; 2019 Sep; 65(3):550-557. PubMed ID: 31372821
[TBL] [Abstract][Full Text] [Related]
8. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
Barb D; Bril F; Kalavalapalli S; Cusi K
J Clin Endocrinol Metab; 2019 Aug; 104(8):3327-3336. PubMed ID: 30848827
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin-like growth factor-I in diabetic retinopathy.
Payne JF; Tangpricha V; Cleveland J; Lynn MJ; Ray R; Srivastava SK
Mol Vis; 2011; 17():2318-24. PubMed ID: 21921983
[TBL] [Abstract][Full Text] [Related]
10. Associations between FGF21, osteonectin and bone turnover markers in type 2 diabetic patients with albuminuria.
Xu L; Niu M; Yu W; Xia W; Gong F; Wang O
J Diabetes Complications; 2017 Mar; 31(3):583-588. PubMed ID: 27916484
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin may play a part in the pathogenesis of diabetic retinopathy.
Yilmaz MI; Sonmez A; Acikel C; Celik T; Bingol N; Pinar M; Bayraktar Z; Ozata M
Eur J Endocrinol; 2004 Jul; 151(1):135-40. PubMed ID: 15248834
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between serum sialic acid levels and retinopathy in Type 2 diabetic patients.
Deepa R; Rema M; Mohan V
Diabetes Res Clin Pract; 1998 Sep; 41(3):165-9. PubMed ID: 9829344
[TBL] [Abstract][Full Text] [Related]
13. The relationship between serum levels of fibroblast growth factor 21 and diabetic retinopathy.
Mousavi Z; Bonakdaran S; Sahebkar A; Yaghoubi G; Yaghoubi MA; Davoudian N; Mohebbi M
EXCLI J; 2017; 16():1249-1256. PubMed ID: 29285020
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of N(ε)- Carboxy methyl lysine (N(ε)-CML) are associated with topographic alterations in retinal pigment epithelium: A preliminary study.
Mishra N; Saxena S; Ruia S; Prasad S; Singh V; Khanna V; Staffa R; Gaspar L; Kruzliak P
J Diabetes Complications; 2016 Jul; 30(5):868-72. PubMed ID: 27039312
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.
Aso Y; Inukai T; Tayama K; Takemura Y
Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin, Insulin Sensitivity and Diabetic Retinopathy in Latinos With Type 2 Diabetes.
Kuo JZ; Guo X; Klein R; Klein BE; Genter P; Roll K; Hai Y; Goodarzi MO; Rotter JI; Chen YD; Ipp E
J Clin Endocrinol Metab; 2015 Sep; 100(9):3348-55. PubMed ID: 26020763
[TBL] [Abstract][Full Text] [Related]
17. Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy.
Reddy S; Amutha A; Rajalakshmi R; Bhaskaran R; Monickaraj F; Rangasamy S; Anjana RM; Abhijit S; Gokulakrishnan K; Das A; Mohan V; Balasubramanyam M
J Diabetes Complications; 2017 May; 31(5):804-809. PubMed ID: 28336215
[TBL] [Abstract][Full Text] [Related]
18. High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy.
Kim CH; Park HJ; Park JY; Hong SK; Yoon YH; Lee KU
Diabetes Care; 1998 Dec; 21(12):2149-51. PubMed ID: 9839109
[TBL] [Abstract][Full Text] [Related]
19. Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients.
Zhang X; Hu Y; Zeng H; Li L; Zhao J; Zhao J; Liu F; Bao Y; Jia W
Cardiovasc Diabetol; 2015 Mar; 14():32. PubMed ID: 25850006
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes.
Reinehr T; Karges B; Meissner T; Wiegand S; Fritsch M; Holl RW; Woelfle J
J Clin Endocrinol Metab; 2015 Aug; 100(8):3004-10. PubMed ID: 26052728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
